Shaokun Shu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors.
Journal: Science advances
Published: January 16, 2026
Cisplatin-Induced ecDNA Enhances Tumor Aggressiveness and Accelerates Chemoresistance Acquisition in Gastric Cancer.
Journal: Journal of advanced research
Published: January 01, 2026
Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury.
Journal: Nature communications
Published: November 24, 2024
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenome.
Journal: Nature methods
Published: August 13, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Journal: Cell reports
Published: June 01, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.
Journal: Molecular cancer therapeutics
Published: May 18, 2023
Publisher Correction: FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5'-end single-cell RNA sequencing.
Journal: Genome biology
Published: April 21, 2023
The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium.
Journal: Nature communications
Published: November 27, 2022
Understanding metabolic reprogramming in tumor microenvironment.
Journal: Medical review (2021)
Published: February 14, 2022
Last Updated: 09/26/2026